Abrau Durso OAO (ABRD)
Moscow Exchange · Russia · prices in RUB · close of 19 Oct 2026
Key indicators
| Last close | RUB 119.00 |
|---|---|
| 52-week range | 98.20 – 178.60 |
| Return, 1 month / 3 months | +2.8% / +7.6% |
| Return, 1 year / 3 years | −24.9% / −59.4% |
| Trend | Below its 200-day average |
| RSI (14) | 62 |
| Volatility (1 year) | 22.6% |
| Worst drawdown (1 year) | -40.1% |
| Average daily value traded | 3.43M RUB |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Abrau Durso is a Russian wine producer based at the Abrau-Durso estate near Novorossiysk on the Black Sea coast. The company makes sparkling wines, including traditional-method sparkling wines, along with still wines and other drinks, and it sells them through retail and hospitality channels in Russia. It also runs visitor facilities at its estate, such as guided tours, tasting rooms and dining, which draw tourists to the winery.
On this site Abrau Durso OAO appears as a stock on the Moscow Exchange (Russia), code ABRD, with prices in Russian rubles (RUB). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Abrau Durso OAO (ABRD) trades on the Moscow Exchange in Russia. It last closed at RUB 119.00 on 19 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 137 of 250 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 24.9% and over the last three months it rose 7.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Moscow Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 38 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -13.0% | ||
| From 52-week high | -29.3% | ||
| Momentum | 35 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 7.6% | ||
| 6-month return | -21.5% | ||
| 12-month return, skipping the last month | -26.9% | ||
| Stability (higher is calmer) | 80 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 22.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -40.1% | ||
| Liquidity | 36 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 3.43M RUB | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.1% |
|---|---|
| 1 month | +2.8% |
| 3 months | +7.6% |
| 6 months | −21.5% |
| 1 year | −24.9% |
| 3 years | −59.4% |
| 5 years | −40.2% |
Signals
| 50-day / 200-day average | 115.80 / 136.74 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.80 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Jul 2022 | RUB 3.4400 |
| 9 Jul 2021 | RUB 2.8600 |
| 16 Oct 2020 | RUB 1.0300 |
| 9 Jul 2019 | RUB 2.8600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Moscow Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.